Overview
Keigo Araki practices practicing medicine in Hirakata, Japan.
Mr. Araki is highly rated in 1 condition, according to our data. His clinical expertise encompasses Retinoblastoma, Adult T-Cell Leukemia, Non-Small Cell Lung Cancer (NSCLC), and Lung Cancer.
He is actively involved in clinical research, co-authoring 28 peer reviewed articles.
Gender
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Keigo Araki
Is Keigo Araki a top-rated expert for Retinoblastoma?
MediFind is an objective health platform that identifies experts based on real-world data. Keigo Araki is classified as an Advanced expert for Retinoblastoma, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Keigo Araki participate in research or clinical trials?
Yes. Keigo Araki has published 28 articles and abstracts on conditions like Retinoblastoma. You can view a list of Keigo Araki's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- RetinoblastomaMr. Araki isAdvanced. Learn about Retinoblastoma.
- Experienced
- Adult T-Cell LeukemiaMr. Araki isExperienced. Learn about Adult T-Cell Leukemia.
- Lung CancerMr. Araki isExperienced. Learn about Lung Cancer.
- Non-Small Cell Lung Cancer (NSCLC)Mr. Araki isExperienced. Learn about Non-Small Cell Lung Cancer (NSCLC).